Menu
Back to User profile » Dr Ayca Ozol-Godfrey
Papers published by Dr Ayca Ozol-Godfrey:
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1347-1348
Published Date: 14 May 2021
Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD
Putcha N, Ozol-Godfrey A, Sanjar S, Sharma S
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1061-1073
Published Date: 19 April 2021
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
Tashkin DP, Ozol-Godfrey A, Sharma S, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:945-955
Published Date: 12 April 2021
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies
Hanania NA, Yohannes AM, Ozol-Godfrey A, Tocco M, Goodin T, Sharma S, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:865-875
Published Date: 31 March 2021
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]
Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1177-1178
Published Date: 26 May 2020
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:995-1004
Published Date: 6 May 2020
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies
Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:745-754
Published Date: 14 April 2020
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies
Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:461-470
Published Date: 19 February 2019